Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
The Lancet Regional Health. Europe|July 11, 2022
Management of gout following 2016/2017 European (EULAR) and British (BSR) guidelines: An interrupted time-series analysis in the United KingdomMark D Russell, Andrew I Rutherford, Benjamin Ellis, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 19, 2023
The Clinical Impact of Electronic Patient-Reported Outcome Measures in the Remote Monitoring of Inflammatory Arthritis: A Systematic Review and Meta-analysisNikita Arumalla, Chun K D Chan, Mark Gibson, et al.
Infection|July 15, 2025
Rising rates of sepsis in England: an ecological studyVictoria B Allen, Katie Bechman, Mark D Russell, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 11, 2020
Venous Thromboembolism Risk With JAK Inhibitors: A Meta-AnalysisMark Yates, Amanda Mootoo, Maryam Adas, et al.
Rheumatology (Oxford, England)|February 4, 2021
Disease activity and its predictors in early inflammatory arthritis: findings from a national cohortMark Yates, Joanna M Ledingham, Paul Amlani Hatcher, et al.
BMJ Open|December 15, 2022
Changing trends in ethnicity and academic performance: observational cohort data from a UK medical schoolProkriti Mukherji, Maryam A Adas, Benjamin Clarke, et al.
Rheumatology (Oxford, England)|November 10, 2022
Treat-to-target urate-lowering therapy and hospitalizations for gout: results from a nationwide cohort study in EnglandMark D Russell, Edward Roddy, Andrew I Rutherford, et al.
Rheumatology (Oxford, England)|August 12, 2025
Risk of venous thromboembolism in people with rheumatoid arthritis: a population-based study in the UKMark D Russell, Katie Bechman, Mark Gibson, et al.
Annals of the Rheumatic Diseases|May 7, 2013
The risk of gastrointestinal perforations in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the BSRBR-RAJakub Závada, Mark Lunt, Rebecca Davies, et al.
Rheumatology (Oxford, England)|December 15, 2012
Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general populationLouise K Mercer, Rebecca Davies, James B Galloway, et al.
Pageof 8